· FDA批準甲狀旁腺功能減退激素替代療法palopegteri... | 2024-08-29 11:06:35 |
· 罕見肝病新藥“elafibranor”獲FDA批準上市 | 2024-06-13 16:56:31 |
· Atorvastatin Calcium reference... | 2024-04-15 15:17:33 |
· 強生/傳奇生物CAR-T療法新適應癥獲FDA批準 | 2024-04-07 14:20:54 |
· 羅氏眼科雙抗faricimab新適應癥獲FDA批準 | 2023-11-02 11:13:44 |
· 安斯泰來新機制眼科藥物Izervay獲FDA批準上市 | 2023-09-21 15:37:02 |
· 安斯泰來新機制眼科藥物獲FDA批準上市 | 2023-08-14 16:31:30 |
· 2022年全球新上市十大重磅創新藥品 | 2022-12-15 10:29:03 |
· 華東醫藥:子公司合作研發ADC藥物ELAHERE獲美國FDA... | 2022-11-16 15:32:51 |
· Atorvastatin side chain (A8) r... | 2022-10-14 14:35:59 |
· Atorvastatin parent nucleus (L... | 2022-10-14 14:33:45 |
· Atorvastatin side chain (A8) r... | 2022-08-18 11:32:49 |
· 賽生藥業引進的小分子偶聯藥物獲批臨床 | 2022-06-17 14:46:54 |
· 輝瑞非酒精性脂肪性肝炎組合療法獲FDA快速通道資格 | 2022-05-31 15:48:00 |
· ADC藥物Mirvetuximab獲FDA優先審評,華東醫藥... | 2022-05-24 18:00:29 |
· Atorvastatin parent nucleus (M... | 2022-05-19 15:42:54 |
· Atorvastatin side chain (A8) r... | 2022-05-19 15:40:51 |
· 華東醫藥合作伙伴卵巢癌ADC藥物Mirvetuximab ... | 2022-03-21 15:56:47 |
· 輝瑞第三代ALK抑制劑Lorviqua(洛拉替尼)獲歐盟上市... | 2022-02-14 14:40:29 |
· Atorvastatin side chain (A8) r... | 2022-01-12 17:30:25 |
· 吉利德3季報:Biktarvy單季破紀錄23億美元,瑞德西韋... | 2021-11-05 11:17:06 |
· TCR2與百時美施貴寶合作:評估gavo-cel、Opdiv... | 2021-10-26 16:25:56 |
· FDA批準干眼癥新藥Tyrvaya(伐尼克蘭,鼻噴霧劑) | 2021-10-19 14:26:43 |
· FDA批準吉利德低劑量HIV兒科新藥Biktarvy(必妥維... | 2021-10-19 14:22:05 |
· 賽生藥業/TARVEDA就HSP90-PI3K小分 | 2021-09-17 11:31:57 |
· Atorvastatin side chain (A8) r... | 2021-08-13 17:39:30 |
· AI賦能PROTAC研發,英矽智能與Arvinas達成合作 | 2021-08-10 14:38:08 |
· Atorvastatin side chain (A8) r... | 2021-08-06 17:39:13 |
· 百時美施貴寶Opdivo聯合Yervoy治療惡性胸膜間皮瘤在... | 2021-08-05 14:32:01 |
· 百時美施貴寶Opdivo+Yervoy組合療法治療頭頸癌3期... | 2021-07-19 11:10:53 |
· Hepion非酒精性脂肪性肝炎新藥CRV431達到2a期試驗... | 2021-07-14 15:59:23 |
· 武田Darvadstrocel申請用于管腔克羅恩病 | 2021-02-22 08:58:43 |
· 華東醫藥獲雙特異性抗體PRV-3279大中華區權益 | 2021-02-18 10:10:07 |
· Atorvastatin side chain (A8) r... | 2021-01-20 14:13:20 |
· Etranacogene dezaparvovec血友病B三... | 2020-12-10 07:52:04 |
· Atorvastatin parent nucleus (L... | 2020-12-03 15:39:30 |
· Atorvastatin side chain (A8) r... | 2020-12-03 15:28:34 |
· 美批準Imfinzi(durvalumab)新給藥方案 | 2020-11-23 04:51:06 |
· Atorvastatin Calcium reference... | 2020-10-27 15:27:04 |
· Atorvastatin parent nucleus (L... | 2020-10-27 15:24:54 |
· Atorvastatin side chain (A8) r... | 2020-10-27 15:24:12 |
· 華東醫藥獲抗體偶聯藥物Mirvetuximab Soravt... | 2020-10-20 10:15:09 |
· 美批準Opdivo聯合Yervoy用于胸膜間皮瘤 | 2020-10-09 08:23:50 |
· Atorvastatin Calcium reference... | 2020-09-24 14:33:48 |
· Atorvastatin parent nucleus (L... | 2020-09-24 14:31:38 |
· Atorvastatin side chain (A8) r... | 2020-09-24 14:30:24 |
· Rosuvastatin intermediate (D5)... | 2020-08-04 12:23:55 |
· Atorvastatin parent nucleus (L... | 2020-08-04 12:23:15 |
· Atorvastatin side chain (A8) r... | 2020-08-04 12:22:13 |
· Haisen to increase Atorvastati... | 2020-07-02 15:39:53 |